glp-1 news 2025 october 9 Who Gets the Shot? Access by State The GLP-1 Revolution Continues

This Sunday's issue of Plain Medicine breaks down who qualifies, how to access the benefit, and what to ask your provider before July 1

Epidemiological studies suggest a higher incidence of PD among individuals with T2DM, with growing evidence that diabetes may accelerate the onset and progression of motor and cognitive symptoms

Order online for pickup or delivery!

A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight increase in new diabetic retinopathy cases but fewer severe eye complications, including a reduced risk of blindness

However, few research has explored its role o...

After years of fighting over compounded weight loss drugs, Hims & Hers and Novo Nordisk are teaming up to sell Ozempic and Wegovy a shift that could raise costs for patients.